Lufa Farms is an innovative agricultural company based in Montreal, specializing in sustainable urban farming through rooftop greenhouses. They grow a variety of vegetables hydroponically and partner with local farmers to offer a diverse range of fresh, local products via their online Marketplace. With over 500,000 square feet of greenhouse space, Lufa Farms aims to reconnect consumers with their food sources while promoting responsible consumption. Their unique business model not only addresses urban food supply challenges but also emphasizes community engagement through initiatives like their Direct Giving Program, which provides food access to local families. Lufa Farms has established a strong market position as a pioneer in rooftop farming, contributing to the growing demand for sustainable food systems.
Cellworks is a life sciences technology company focused on personalized cancer therapy through advanced biosimulation. Their innovative platform, the Therapy Response Index (TRI), predicts successful drug matches for patients, enhancing treatment outcomes and reducing costs in drug development. Founded in 2005, Cellworks leverages AI to provide actionable insights for oncologists, improving clinical trial success rates and offering transparency in therapy selection. The company collaborates with leading organizations and has a strong team of experts in molecular biology and software technology, positioning itself as a leader in precision medicine for oncology and immunology.
CyberSaint is a leading provider of cyber risk management solutions, offering the Cyber Strong platform that integrates security operations, continuous compliance, and risk management. The platform is designed for CISOs and IT compliance teams, enabling them to automate compliance assessments, quantify risks in financial terms, and communicate their cyber risk posture effectively. With patented AI technology, CyberSaint differentiates itself by providing real-time insights and a holistic view of cyber risk, which is essential for informed decision-making at the executive level. The company has gained traction among Fortune 500 clients and is recognized as a Gartner Cool Vendor, showcasing its strong market position and innovative approach to cyber risk management.
Virsec is a cybersecurity company that specializes in Zero Trust Runtime Defense for server workloads. Their flagship product, the Virsec Security Platform (VSP), provides comprehensive protection against malware, ransomware, and zero-day attacks by enforcing trusted execution and stopping malicious code in milliseconds. The platform is designed to protect legacy and out-of-support applications, alleviating the need for panic patching and ensuring system integrity. With a focus on continuous protection and visibility into running workloads, Virsec differentiates itself through its patented technology and has gained traction in various industries, including healthcare, financial services, and public sector.
Lumicell is on a mission to transform cancer surgery with its fluorescence imaging technology, designed to illuminate residual cancer in real-time. The company's lead product, LUMISIGHT™ (pegulicianine), has recently received FDA approval and is aimed at improving surgical outcomes by enabling surgeons to identify and excise cancerous tissue more effectively during procedures. Lumicell's innovative approach differentiates it in the market by focusing on real-time imaging, which has shown proven effectiveness in clinical trials. The company is scaling its operations and has received recognition through various awards and contracts, indicating strong traction in the healthcare sector. Lumicell is positioned to make a significant impact in the oncology space, particularly in breast cancer surgery, while also exploring applications in other cancer types.